Cooperative Allosteric Transitions
Allosteric Proteins-ATCase
Allosteric Regulation
Ligand Binding and Linkage
Protein Folding
The Unfolded Protein Response
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 1, 2025

Designing Silk-silk Protein Alloy Materials for Biomedical Applications
Published on: August 13, 2014
Ruth Nussinov1,2, Mingzhen Zhang1, Yonglan Liu3
1Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.
This article reviews how artificial intelligence tools like AlphaFold have transformed structural biology while identifying current limitations in modeling dynamic protein behaviors such as allostery and conformational changes.
Area of Science:
Background:
No consensus exists regarding the full scope of artificial intelligence in predicting complex protein dynamics. Prior research has shown that sequence-based modeling provides static structural snapshots with high accuracy. That uncertainty drove interest in whether these tools could capture the nuanced conformational ensembles required for biological signaling. It was already known that protein function often relies on flexible states rather than rigid shapes. This gap motivated an investigation into the current capabilities of deep learning in structural biology. Prior studies have highlighted the success of these algorithms in predicting stable protein folds. However, the field remains divided on how these models represent the inherent flexibility of biological molecules. No prior work had resolved the specific limitations regarding allosteric mechanisms and protein folding pathways.
Purpose Of The Study:
The aim of this article is to overview the role of artificial intelligence in structural biology. This work addresses the transformative impact of deep learning on protein structure prediction. The authors seek to clarify the current limitations of these algorithms in capturing dynamic protein behaviors. This study explores the distinction between static structural models and the ensembles required for signaling. The researchers aim to evaluate how these tools influence drug discovery and clinical trial design. This paper investigates the challenges associated with modeling intrinsically disordered proteins. The authors intend to provide a balanced perspective on the strengths and weaknesses of modern computational approaches. This review serves to guide future research by highlighting where deep learning currently falls short in biological modeling.
Main Methods:
The review approach synthesizes current literature regarding artificial intelligence applications in structural biology. Authors evaluate the integration of deep learning with molecular dynamics simulations. This analysis focuses on the predictive accuracy of protein-protein interactions within microbiota-human systems. The investigation examines how structural databases influence modern drug discovery workflows. Researchers compare the outputs of deep learning algorithms against established biophysical principles of protein folding. The study assesses the capacity of these models to represent conformational ensembles. This evaluation includes a critical look at how structural probabilities are assigned to disordered regions. The methodology centers on identifying the gap between static structural predictions and dynamic biological signaling.
Main Results:
Key findings from the literature indicate that AlphaFold provides powerful insights into protein structure prediction. The authors report that these models successfully leverage biological sequence data to create extensive structural databases. Results demonstrate that deep learning techniques currently fail to resolve the decades-long protein folding challenge. The analysis shows that these algorithms do not identify specific folding pathways. Findings reveal that models cannot capture conformational mechanisms like frustration or allostery. The review notes that these tools generate single ranked structures rather than the required conformational ensembles. Evidence suggests that these models describe disordered proteins through low structural probabilities. The literature confirms that deep learning cannot yet elucidate the mechanisms of allosteric drug resistance.
Conclusions:
The authors suggest that deep learning models provide a foundation for future conformational ensemble generation. They propose that these tools currently lack the capacity to resolve protein folding pathways directly. The researchers note that single static structures fail to capture the dynamic nature of allosteric signaling. They emphasize that these models do not account for the ensemble-based properties of disordered protein regions. The paper indicates that current algorithms cannot identify the drivers of allosteric drug resistance. The authors argue that these limitations stem from the reliance on single ranked structural outputs. They highlight that future progress requires integrating deep learning with dynamic simulation techniques. The review concludes that while these advancements are significant, they do not yet replace traditional biophysical methods for studying protein populations.
The researchers propose that AlphaFold fails to elucidate allosteric activating driver hotspot mutations because it generates single ranked structures. In contrast, traditional biophysical methods analyze populations to capture the dynamic distributions necessary for understanding allosteric signaling.
The authors define allostery as a property of populations controlled by dynamic distributions. Unlike static models, this concept requires understanding how ensembles of protein conformations behave under varying conditions to facilitate biological signaling.
The researchers suggest that deep learning techniques can use a single predicted conformation as a starting point. By applying these methods, scientists may generate a diverse ensemble of protein structures to overcome the limitations of static structural predictions.
AlphaFold describes intrinsically disordered proteins by assigning them low structural probabilities. This approach differs from ensemble-based modeling, which explicitly maps the various flexible states these regions occupy within a biological system.
The authors highlight that these models do not capture conformational mechanisms like frustration. This phenomenon is rooted in the energy landscapes of protein ensembles, which remain inaccessible to algorithms that only provide a single, ranked structural prediction.
The researchers propose that artificial intelligence could revolutionize personalized treatments and clinical trials. They claim these tools will reshape drug discovery strategies by prioritizing combinations of targets more effectively than previous methods.